Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
12.23
+0.03
+(0.20%)
As of 2:00:22 PM GMT. Market Open.
Breakdown
TTM
12/31/2020
Total Revenue
--
741.07
Cost of Revenue
--
282.32
Gross Profit
--
458.75
Operating Expense
--
417.08
Operating Income
--
41.67
Net Non Operating Interest Income Expense
--
-53.66
Pretax Income
--
-11.99
Net Income Common Stockholders
--
-11.99
Diluted NI Available to Com Stockholders
--
-11.99
Basic EPS
--
-0.00
Diluted EPS
--
-0.00
Basic Average Shares
121,666.67
121,666.67
Diluted Average Shares
121,666.67
121,666.67
Total Operating Income as Reported
--
-13.28
Total Expenses
--
699.40
Net Income from Continuing & Discontinued Operation
--
-11.99
Normalized Income
--
-11.99
Interest Expense
--
53.66
Net Interest Income
--
-53.66
EBIT
--
41.67
EBITDA
--
79.28
Reconciled Cost of Revenue
--
282.32
Reconciled Depreciation
36.79
37.61
Net Income from Continuing Operation Net Minority Interest
--
-11.99
Normalized EBITDA
--
79.28
12/31/2020 - 3/31/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OPTI.L OptiBiotix Health Plc
18.48
+1.26%
SBTX.L SkinBioTherapeutics plc
19.95
-0.77%
TYPTF
0.0112
0.00%
OBI.L Ondine Biomedical Inc.
10.48
-10.47%
GNS.L Genus plc
1,812.00
-1.63%
ELTX Elicio Therapeutics, Inc.
8.31
+0.48%
HVO.L hVIVO plc
16.22
-1.69%
NEUP Neuphoria Therapeutics Inc.
5.20
+0.19%
SNGX Soligenix, Inc.
2.3100
+2.67%
PPCB Propanc Biopharma, Inc.
6.75
0.00%